FRA:CXX • US1890541097
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CLOROX COMPANY (CXX.DE).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2021-08-04 | Atlantic Equities | Downgrade | Overweight -> Neutral |
| 2021-08-04 | DA Davidson | Maintains | Neutral |
| 2021-08-04 | Deutsche Bank | Maintains | Hold |
| 2021-08-04 | RBC Capital | Maintains | Sector Perform |
| 2021-08-04 | Credit Suisse | Maintains | Neutral |
| 2021-08-04 | Morgan Stanley | Maintains | Underweight |
| 2021-07-26 | Deutsche Bank | Maintains | Hold |
| 2021-06-24 | UBS | Initiate | Sell |
| 2021-05-21 | Argus Research | Maintains | Buy |
| 2021-05-04 | Jefferies | Maintains | Hold |
| 2021-05-03 | DA Davidson | Maintains | Neutral |
| 2021-05-03 | Deutsche Bank | Maintains | Hold |
| 2021-05-03 | Wells Fargo | Downgrade | Equal-Weight -> Underweight |
| 2021-05-03 | Credit Suisse | Maintains | Neutral |
| 2021-05-03 | Morgan Stanley | Maintains | Underweight |
| 2021-04-21 | Deutsche Bank | Maintains | Hold |
| 2021-04-19 | Morgan Stanley | Maintains | Underweight |
| 2021-04-16 | JP Morgan | Maintains | Neutral |
| 2021-03-18 | DA Davidson | Downgrade | Buy -> Neutral |
| 2021-02-19 | Atlantic Equities | Upgrade | Neutral -> Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 7.389B 3.97% | 7.093B -4.01% | 7.104B 0.16% | 6.559B -7.67% | 7.029B 7.17% | 7.277B 3.53% | 7.359B 1.13% | 7.63B 3.68% | 7.943B 4.10% | 8.255B 3.93% | 8.586B 4.01% | |
| EBITDA YoY % growth | 1.048B 11.97% | 1.156B 10.31% | 1.404B 21.45% | 1.286B -8.40% | 1.465B 13.92% | 1.54B 5.12% | 1.612B 4.68% | 1.693B 5.02% | 1.759B 3.90% | 1.837B 4.43% | 1.919B 4.46% | |
| EBIT YoY % growth | 812M 14.04% | 921M 13.42% | 1.185B 28.66% | 1.066B -10.04% | 1.232B 15.57% | 1.316B 6.82% | 1.4B 6.38% | 1.478B 5.57% | 1.522B 2.98% | 1.591B 4.53% | 1.663B 4.53% | |
| Operating Margin | 10.99% | 12.98% | 16.68% | 16.25% | 17.53% | 18.08% | 19.02% | 19.37% | 19.16% | 19.27% | 19.37% | |
| EPS YoY % growth | 5.09 23.84% | 6.18 21.41% | 7.73 25.08% | 5.96 -22.86% | 6.81 14.19% | 7.21 5.95% | 8.14 12.76% | 8.70 6.89% | 9.00 3.48% | 9.62 6.85% | 10.27 6.83% |
All data in USD
| Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.59 9.41% | 2.11 -26.47% | 1.41 65.57% | 1.62 16.53% | 1.71 7.99% | 2.17 2.68% | 1.59 12.67% | 1.71 5.80% | 1.79 4.74% | 2.33 7.67% |
| Revenue Q2Q % growth | 1.689B 1.26% | 1.748B -12.07% | 1.636B 14.49% | 1.704B 1.85% | 1.725B 2.13% | 1.812B 3.66% | 1.721B 5.20% | 1.761B 3.35% | 1.772B 2.72% | 1.884B 3.97% |
| EBITDA Q2Q % growth | 336.1M -16.81% | 422.49M -35.10% | 300.89M 71.94% | 335.06M -3.16% | 348.13M 3.58% | 430.97M 2.01% | 328.25M 9.09% | 350.2M 4.52% | 353.68M 1.59% | 452.02M 4.88% |
| EBIT Q2Q % growth | 281.35M 16.26% | 367.69M -14.89% | 248.07M 108.46% | 281.63M 19.84% | 296.12M 5.25% | 379.51M 3.21% | 279.58M 12.70% | 302.06M 7.25% | 304.83M 2.94% | 401.38M 5.76% |
All data in USD
27 analysts have analysed CXX.DE and the average price target is 104.36 EUR. This implies a price decrease of -3.37% is expected in the next year compared to the current price of 108.
CLOROX COMPANY (CXX.DE) will report earnings on 2026-05-04, after the market close.
The consensus EPS estimate for the next earnings of CLOROX COMPANY (CXX.DE) is 1.59 EUR and the consensus revenue estimate is 1.69B EUR.
The number of analysts covering CLOROX COMPANY (CXX.DE) is 27.